Top 10 Prostate Cancer Articles of 2016

Top 10 Prostate Cancer Articles of 2016
A number of important discoveries, therapeutic developments, and events related to prostate cancer were reported daily by Prostate Cancer News Today throughout 2016. Now that the year is over, it is time to briefly review the articles that appealed most to our readers. Here are the top 10 most-read articles of 2016, with a brief description of what made them interesting and relevant to prostate cancer patients, family members and caregivers. No. 10 - "Scientists Identify Biomarker for Advanced Prostate Cancer as Specific Androgen Receptor in Circulating Cancer Cells" This article demonstrates that the response to androgen deprivation therapy can be predicted by the presence of an alternative RNA form, or slice variant, of the androgen receptor in circulating tumor cells. The research therefore suggests that a simple blood test could predict the likelihood of a patient progressing to metastatic castration-resistant prostate cancer, which is associated with shorter overall survival. But importantly, not everything was bad news for patients with the androgen-receptor splice variant 7, as these patients were found to survive for longer periods when treated with taxane-based chemotherapy. No. 9 - "Studies That Led to FDA Approval of Axumin as Prostate Cancer Imaging Agent Presented at SNMMI 2016" Understanding whether a prostate cancer patient recurred after initial treatment became facilitated with the approval of a new PET scan tracer, called Axumin. The agent, which consists of a synthetic amino acid coupled with a radioactive chemical, is preferentially taken up by prostate cancer cells, allowing researchers to identify not only the extent of the cancer recurrence, but also its location, which may help doctors defining the most appropriate treatment for these pa
Subscribe or to access all post and page content.